about
Practical Applications of New Agents in Oncology is a nationally recognized conference for health care professionals designed to give them information on results of clinical studies of new anticancer agents and current treatment strategies. National experts presenting at this conference will be addressing these needs and sharing their knowledge and expert opinion. In addition, attendees will gain the knowledge of how to use pharmacogenomics and personalized medicine approaches to help in the selection of novel new therapies for patients.
The conference will give an up-to-date review of recently approved new agents and promising investigational agents in oncology and hematology, and will provide educational opportunities for hematology/oncology fellows, nurse practitioners, physician assistants, Registered nurses, pharmacists, and clinical research coordinators. Topics will include approved novel targeted therapies and immune checkpoint therapies and those likely to be approved, underlying molecular mechanisms for new drug development, drug development pipelines, the transition from drug development in biopharmaceuticals, clinical trials, palliative care, survivorship and strategies to manage cancer patients during the ongoing COVID-19 pandemic. It is a continuing education (CME) activity designed for health care professionals specializing in oncology and hematology.
program
2022 PANAO RESOURCES
PRESENTATION SLIDES
(Click on the name below to view presentation pdf)
Presentations/posters are the intellectual property of the author/presenter. Contact the author/presenter for permission to reprint and/or distribute.
AWARD WINNERS
Karla Haggerty
Institute for Drug Development Research Nurse Award
A Day in the Life - A Coordinators Perspective
Kayla Chamberlin
Institute for Drug Development Research Nurse Award
Digital Patient Navigation with "Agilix Health" Tech-enabled Remote Care and Monitoring of Cancer Patients
Suvam Banerjee
2022 Practical Applications of New Agents in Oncology Poster Award
Hormone Therapy in the management of stage four (4) Breast Cancer (Asymptomatic metastasis) in females
Gabriel Roman Souza
2022 Practical Applications of New Agents in Oncology Poster Award
A Single Institution Retrospective Analysis of Off-Label Drug Use in Patients with Actionable Genomic Alterations of Next Generation Sequencing
Gabriel Roman Souza
2022 Practical Applications of New Agents in Oncology Poster Award
Sebaceous Carcinoma of the Eyelid in a Patient with Muir-Torre Syndrome Treated with Pembrolizumab
SPEAKERS
Elizabeth Bowhay-Carnes, MD
Texas Oncology
Matthew Butler, MD
UT Health San Antonio
MD Anderson Cancer Center
Kayla Chamberlin, BSN, RN
UT Health San Antonio MD Anderson Cancer Center
Aaron Goldman, PhD
Harvard Medical School
Adolfo Enrique Diaz Duque, MD, MSc
UT Health San Antonio
MD Anderson Cancer Center
Karla Hagerty, BSN, RN
UT Health San Antonio
MD Anderson Cancer Center
Robert Hromas, MD
UT Health San Antonio
Virginia Kaklamani, MD
UT Health San Antonio MD Anderson Cancer Center
Supreet Kaur, MD
UT Health San Antonio MD Anderson Cancer Center
Yasmin A. Lyons, DO, MS
UT Health San Antonio
Daruka Mahadevan, MD, PhD (Speaker & Moderator)
UT Health San Antonio MD Anderson Cancer Center
Mitesh Borad, MD
Mayo Clinic
Hussein Tawbi, MD, PhD
UT MD Anderson Cancer Center
Ruben A. Mesa, MD, FACP
UT Health San Antonio MD Anderson Cancer Center
Zohra Nooruddin, MBBS
UT Health San Antonio
Shreyaskumar Patel, MD
UT MD Anderson Cancer
Center
Patrick G. Pilie, MD
UT MD Anderson Cancer Center
Ramesh Ramanathan, MD
Merck Research Labs
George Simon, MD
Moffitt Cancer Center
Jason Westin, MD, MS, FACP
UT MD Anderson Cancer Center
Shruti Pandita, MD
UT Health San Antonio
MD Anderson Cancer Center
Sukeshi Patel-Arora, MD (Moderator)
UT Health San Antonio MD Anderson Cancer Center
Chethan Ramamurthy, MD (Moderator)
UT Health San Antonio MD
Anderson Cancer Center
John Sarantopoulos, MD (Moderator)
UT Health San Antonio MD
Anderson Cancer Center
EXHIBITORS
Sponsorship
Mobile App Sponsor- Bristol Myers Squibb
Grants
This activity is supported by education grants provided by Astra-Zeneca, Novartis & Pfizer.
CONTINUING EDUCATION
Continuing Medical Education
The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The UT Health Science Center San Antonio designates this live activity up to a maximum of 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the polling and evaluation components, enables the participant to earn MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Continuing Nursing Education
University of Texas Health Science Center at San Antonio is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Up to 14.33 contact hours will be awarded to registered nurses for attending the entire conference.
Click here to view Financial Disclosures
As an ACCME-accredited CME provider, UT Health Science Center San Antonio must ensure that its CME activities are independent of the control of commercial interests. All speakers and planning committee members for the UT Health Science Center San Antonio sponsored programs are expected to disclose (prior to the activity) all “financial relationships” in any amount occurring within the past 24 months. Disclosures are then reviewed to identify any "relevant" financial relationships that create a conflict of interest. (“Relevant” financial interest or other relationships can include such things as grant or research support, employees, consultants, major stockholders, members of speaker bureau, etc.)
The UT Health Science Center San Antonio, Daruka Mahadevan, MD, PhD and John Sarantopoulos, MD, course directors of the activity, have reviewed or designated reviewers to verify all financial disclosure information for all speakers, facilitators, and planning committee members; all relevant financial relationships have been mitigated prior to the start of the activity.
connect with us
UT Health San Antonio MD Anderson Cancer Center
7979 Wurzbach Road, MC 8224
San Antonio, TX 78229
P: (210) 450-1550
Email: panao@uthscsa.edu
WE MAKE LIVES BETTER®
We are part of the UT Health San Antonio, provider of comprehensive health, dental & cancer care, advanced academics and life-saving research.